Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10763403 | 0.79 | SLC6A4 (0.44) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL24066716 | 0.77 | MTNR1A (0.42) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL11402564 | 0.77 | MAOA (0.52) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL10763892 | 0.77 | MTNR1A (0.42) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL1488230 | 0.77 | MTNR1A (0.42) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| Ethane SCHEMBL11445847 | 0.76 | MAOA (0.50) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL19544761 | 0.76 | SLC6A4 (0.42) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL8813184 | 0.76 | TDP1 (0.54) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL11384019 | 0.75 | MTNR1A (0.57) | MTNR1AMTNR1BLMNAGAAMEN1 | |
| SCHEMBL27941499 | 0.74 | MTNR1A (0.47) | MTNR1AMTNR1BLMNAGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126895-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA Script (FR) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198040-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES. | DNA SCRIPT (FR) | 2021-10-07 | — | — | WO | claimed |
| EP-4126895-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA Script (FR) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021198040-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES. | DNA SCRIPT (FR) | 2021-10-07 | — | — | WO | disclosed |
| US-6906046-B2 | Pharmaceutical uses and synthesis of benzobicyclooctanes | CELLTECH R & D INC. (US) | 2005-06-14 | — | — | US | disclosed |
| US-20030069305-A1 | Pharmaceutical uses and synthesis of benzobicyclooctanes | CELLTECH R & D, INC. | 2003-04-10 | — | — | US | disclosed |
| WO-2002051851-A2 | PHARMACEUTICAL USES AND SYNTHESIS OF BENZOBICYCLOOCTANES | CELLTECH R & D, INC. (US) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069305-A1 | Pharmaceutical uses and synthesis of benzobicyclooctanes | CXCL8, CASP8, IL18 | MTNR1A 4342/4885MTNR1B 3818/4885LMNA 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.